The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.
Making the health care system function better could save $2 trillion on health costs over the next decade, Dr. David Blumenthal, Commonwealth Fund president, told CNBC on Friday.
Widespread influenza activity has afflicted 47 states, according to the CDC. Phil Hosbach, VP of Immunization Policy, discusses whether people should be worried about dwindling supplies.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.
Peter Suderman, Reason Magazine, explains whether insurance company premiums are rising under so-called Obamacare. Meanwhile Michael Farr, Farr, Miller & Washington, discusses what that means for health stocks.
The Affordable Care Act will go far to rescue the generation hardest hit by rising health-care costs, including 8.6 million Boomers without health insurance.
States are setting up health insurance exchanges, reports CNBC's Bertha Coombs. Max Nisen, Business Insider, also weighs in.
It's hard to see how lawmakers can avoid touching health insurance if they want to eliminate loopholes and curtail deductions so as to raise revenue and lower tax rates.
Toby Cosgrove, CEO & president at The Cleveland Clinic, explains how "fiscal cliff" cuts could severely impact the health care industry.
Health care costs, especially in drug development remains high despite advancements in medicine. But as Taher Abbasi, CEO of Cellworks tells CNBC's Martin Soong, that is all set to change with innovation.
Christopher Viehbacher, CEO, Sanofi says that as cost rises, the firm is growing its emerging-markets business outside of the BRIC nations.
Merck reported higher-than-expected quarterly results on Friday and said it continued to expect full-year revenue to be at or near 2011 levels on a constant currency basis.
The managing partner of Google's venture capital, Bill Maris, says under-investment in health sciences is short-sighted.
The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.
Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.
The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.
Despite piles of research on the skin cancer risks of sun exposure and tanning beds, dermatologists and cancer groups struggle to persuade people to protect their skin from ultraviolet rays.
The average US refrigerator is 15 percent larger than 30 years ago, and one out of four homes has a second one. See a problem?
Local foods sales are booming, having doubled to $11 billion in the past ten years. Wal-Mart, Safeway and other big firms are trying to cash in.